According to a top WHO expert, mpox is “not the new Covid” because authorities obviously know how to stop its spread.

Together, we could – and must – combat mpox, Dr. Hans Kluge, regional director for Europe, said journalists, despite genuine worries about a new viral type and a worldwide alert. 

And taking decisive action right away, such as making sure vaccines get to the places that need them the most, could break the cycle of fear and disregard. Last week, a case of the novel variation, Clade Ib, was identified in Sweden and connected to an expanding outbreak in Africa.

Mpox has claimed at least 450 lives in the Democratic Republic of Congo recently, linked to Clade Ib. Experts are still learning about this new variant, which may be more transmissible and cause more severe illness.

While Clade Ib has not been detected in the UK, experts caution that it could spread without international intervention. The 2022 outbreak in Europe, driven by Clade II, continues to affect many regions globally. 

Dr. Kluge emphasizes that controlling mpox is possible through inclusive public health measures and fair vaccine distribution. The virus spreads via skin-to-skin contact with lesions, including during sex. Dr. Kluge noted that the general risk remains low and ruled out lockdowns like those seen with Covid-19. 

He highlighted the success of engaging affected communities in Europe two years ago. Now, with around 100 new Clade II cases reported monthly in Europe, Dr. Kluge calls for global collaboration to address mpox, warning against cycles of panic and neglect.

Travelers to affected African regions are advised to consider vaccination. WHO spokesman Tarik Jasarevic stated that while masks and mass vaccination are not currently recommended, vaccines should be used in outbreak settings for high-risk groups.